| Phase |
Objectives |
1st phase
(2002-2005)
Development of
fundamental technology
|
Establishment of human embryonic stem cell lines and management of the stem cell bank |
Elucidation of stem cell markers and signaling pathways |
Development of techniques for stem cell research |
|
2nd phase
(2005-2008)
Development of
core technology
|
Establishment of infrastructure for stem cell research and bioethics |
Characterization and guided differentiation of human stem cells |
Development of stem cell therapy for neural diseases, cardiovascular diseases and other incurable diseases |
|
3rd phase
(2008-2012)
Clinical applications
and industrialization
|
Development of stem cell technology for clinical applications |
Development of technologies for differentiating stem cells and isolating differentiated cells |
Development of stem cell-mediated novel therapeutics |
Establishment of international infrastructure for stem cell research and bioethics |
|